Objective To explore the feasibility and reference value of allogeneic lung transplantation and postoperative monitoring in miniature pigs for lung transplantation research. Methods Two miniature pigs (R1 and R2) underwent left lung allogeneic transplantation. Complement-dependent cytotoxicity tests and blood cross-matching were performed before surgery. The main operative times and partial pressure of arterial oxygen (PaO₂) after opening the pulmonary artery were recorded during surgery. Postoperatively, routine blood tests, biochemical blood indicators and inflammatory factors were detected, and pathological examinations of multiple organs were conducted. Results The complement-dependent cytotoxicity test showed that the survival rate of lymphocytes between donors and recipients was 42.5%-47.3%, and no agglutination reaction occurred in the cross-matching. The first warm ischemia times of D1 and D2 were 17 min and 10 min, respectively, and the cold ischemia times were 246 min and 216 min, respectively. Ultimately, R1 and R2 survived for 1.5 h and 104 h, respectively. Postoperatively, in R1, albumin (ALB) and globulin (GLB) decreased, and alanine aminotransferase increased; in R2, ALB, GLB and aspartate aminotransferase all increased. Urea nitrogen and serum creatinine increased in both recipients. Pathological results showed that in R1, the transplanted lung had partial consolidation with inflammatory cell infiltration, and multiple organs were congested and damaged. In R2, the transplanted lung had severe necrosis with fibrosis, and multiple organs had mild to moderate damage. The expression levels of interleukin-1β and interleukin-6 increased in the transplanted lungs. Conclusions The allogeneic lung transplantation model in miniature pigs may systematically evaluate immunological compatibility, intraoperative function and postoperative organ damage. The data obtained may provide technical references for subsequent lung transplantation research.

Objective The aim of this study was to reveal the association characteristics between cancer and depression u-sing the data from community-based multi-morbidity study in rural China(COMMON),and provide a scientific basis for early pre-vention and intervention of depression in cancer patients.Methods We collected questionnaire responses,physical examination re-cords,health insurance data,and electronic medical records from both cancer and non-cancer participants.Using propensity score matching at a 1∶4 ratio,we balanced baseline characteristics between the cancer and control groups.We then compared the preva-lence of depression between these groups,as well as across subgroups stratified by age,sex,income,and other factors.The association between cancer and depression risk was assessed using univariate and multivariate logistic regression.Finally,we conducted sensitivity analyses by restricting the regression models to participants with mild-to-severe depression.Results After matching the baseline characteristics,a total of 206 cancer patients and 824 controls were included in the study,and all baseline characteristics between the two groups.Among all individuals,women,participants under 60 years old and those from low-income families(10,000-34,999 Yuan per year),the cancer group had a higher prevalence of depression than the non-cancer group(P<0.05),no difference was found in other subgroup(P>0.05).The results of multivariate logistic regression analysis showed that cancer was an independent risk factor for depression,and the risk of depression in cancer patients was 2.38 times that of participants without cancer(95%CI:1.44-3.89,P<0.001).The analysis results of different gender,age,and family income subgroups showed that the effect of cancer on the risk of de-pression was different among subgroups(P<0.05).Conclusions Cancer is an independent risk factor for depression.Therefore,the assessment and intervention of mental health should be paid attention during the treatment of cancer patients.It is of great significance to screen for depression in cancer patients and intervene in them to improve the life quality of patients.In addition,paying attention to high-risk groups can help to implement targeted prevention and intervention and improve their mental health.

Objective The aim of this study was to reveal the association characteristics between cancer and depression u-sing the data from community-based multi-morbidity study in rural China(COMMON),and provide a scientific basis for early pre-vention and intervention of depression in cancer patients.Methods We collected questionnaire responses,physical examination re-cords,health insurance data,and electronic medical records from both cancer and non-cancer participants.Using propensity score matching at a 1∶4 ratio,we balanced baseline characteristics between the cancer and control groups.We then compared the preva-lence of depression between these groups,as well as across subgroups stratified by age,sex,income,and other factors.The association between cancer and depression risk was assessed using univariate and multivariate logistic regression.Finally,we conducted sensitivity analyses by restricting the regression models to participants with mild-to-severe depression.Results After matching the baseline characteristics,a total of 206 cancer patients and 824 controls were included in the study,and all baseline characteristics between the two groups.Among all individuals,women,participants under 60 years old and those from low-income families(10,000-34,999 Yuan per year),the cancer group had a higher prevalence of depression than the non-cancer group(P<0.05),no difference was found in other subgroup(P>0.05).The results of multivariate logistic regression analysis showed that cancer was an independent risk factor for depression,and the risk of depression in cancer patients was 2.38 times that of participants without cancer(95%CI:1.44-3.89,P<0.001).The analysis results of different gender,age,and family income subgroups showed that the effect of cancer on the risk of de-pression was different among subgroups(P<0.05).Conclusions Cancer is an independent risk factor for depression.Therefore,the assessment and intervention of mental health should be paid attention during the treatment of cancer patients.It is of great significance to screen for depression in cancer patients and intervene in them to improve the life quality of patients.In addition,paying attention to high-risk groups can help to implement targeted prevention and intervention and improve their mental health.

OBJECTIVE:To optimize the processing technology of rehmanniae radix praeparata. METHODS:Using transfer rates of catalpol,rehmaionoside D,acteoside,isoacteoside,polysaccharide as indexes for comprehensive score,heating tempera-ture(pressure),heating time and heating times as investigating factors,L9(34)orthogonal test was used to optimize the processing technology of rehmanniae radix praeparata,and verification test was conducted. RESULTS:The optimal processing technology of rehmanniae radix praeparata was as follow as heating temperature of 125 ℃,pressure of 150 kPa for twice,2 h every time. The comprehensive scores of 3 batches of samples were 0.6985,0.6755,0.7016 in the verification test,respectively,RSDs were less than 5%(n=3). CONCLUSIONS:Optimized processing technology is simple,stable,feasible,and can provide reference for in-dustrial production of rehmanniae radix praeparata.

OBJECTIVETo compare the outcomes of patients with adult acute lymphoblastic leukemia (ALL) over the last 14 years by taking 2006 as the demarcation point.

METHODSFrom January 2000 to December 2013, 477 consecutive hospitalized patients with adult ALL were retrospectively analyzed, including 276 (57.9%) with Ph negative B-ALL (Ph⁻-B-ALL) B-ALL, 69 (14.5%) with T-ALL and 132 (27.7%) with Ph positive ALL (Ph⁺-ALL); 111 (23.3%) before 2006 and 366 (76.7%) after 2006. Among 435 patients who achieved complete remission (CR), 248 (57.0%) received allogeneic hematopoietic stem cell transplantation (allo-HSCT), and 187 remained on chemotherapy.

RESULTSWith a median follow-up period of 19 months in all patients and 35 months in living patients, overall CR rate was 92.0%. Of 435 CR patients, the cumulative incidences of 5-year relapse, disease-free survival( DFS) and overall survival (OS) rates were 42.5%, 46.2% and 47.6%, respectively. Compared with the patients hospitalized before 2006: ① the Ph+-ALL patients hospitalized after 2006 achieved a higher overall CR rate (P=0.036). There was no difference for CR rates of Ph--B-ALL and T-ALL patients between before and after 2006. ②The CR patients hospitalized after 2006 had higher 5-year DFS and OS rates (P=0.001; P < 0.001), including higher 5-year OS rate in Ph⁻-B-ALL patients (P=0.046), and higher 5-year DFS and OS rates in both T-ALL (P=0.013; P=0.036) and Ph⁺-ALL patients (P=0.003; P < 0.001) , especially in those Ph⁺-ALL patients who received imatinib from the beginning of the induction chemotherapy (P < 0.001; P < 0.001) ③The patients who received allo-HSCT after 2006 had higher 5-year DFS and OS rates (P=0.001; P < 0.001), but there was no difference for the outcomes in those who remained on chemotherapy before and after 2006. After 2006, Ph⁺-ALL patients who received imatinib from the beginning of the induction chemotherapy had the highest 5-year DFS and OS rates compared with Ph⁻-B-ALL and T-ALL patients (P=0.009; P=0.001) . Multivariate analysis showed that allo-HSCT and imatinib were two important factors affecting the outcomes of ALL patients.

CONCLUSIONThe outcomes of ALL patients improved significantly over the last 14 years, especially in Ph⁺-ALL ones.

Acute Disease ; Adult ; Disease-Free Survival ; Hematopoietic Stem Cell Transplantation ; Humans ; Imatinib Mesylate ; therapeutic use ; Induction Chemotherapy ; Multivariate Analysis ; Precursor Cell Lymphoblastic Leukemia-Lymphoma ; therapy ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma ; therapy ; Recurrence ; Remission Induction ; Retrospective Studies ; Survival Rate